LightAir (LAIR) Q4 2024 earnings summary

Executive summary

• Revenue for 2024 was 16,698 TSEK, nearly flat year-over-year, while costs increased, resulting in a net loss of -26,750 TSEK compared to -16,579 TSEK in 2023.

• EBITDA for the year was -17,958 TSEK, down from -12,914 TSEK, reflecting higher operating expenses and significant write-downs.

• Major cost-cutting actions included the layoff of five employees and a strategic shift to focus on organic growth and distributor partnerships.

• Product development advanced, including new air quality monitoring and industrial air purification systems, and a key healthcare project in Africa demonstrated the effectiveness of LightAir’s technology.

Financial highlights

• Net sales for 2024 were 16,698 TSEK (16,341 TSEK in 2023); B2B sales accounted for 15,856 TSEK, with recurring subscription revenue of 7,244 TSEK.

• EBITDA was -17,958 TSEK (vs. -12,914 TSEK); operating loss was -26,584 TSEK (vs. -16,473 TSEK); net loss per share was -7.69 SEK (-19.69 SEK in 2023, adjusted for share consolidation).

• Cash flow from operations was -14,792 TSEK (vs. -11,172 TSEK); year-end cash was 10,542 TSEK (2,712 TSEK in 2023), supported by a 22,622 TSEK rights issue.

• Equity at year-end was 9,116 TSEK (12,475 TSEK); equity ratio fell to 34.1% from 38.8%.

• No dividend proposed for 2024.

Outlook and guidance

• Focus remains on industrial and commercial segments, with growth targeted via organic expansion and distributor partnerships in Sweden and Finland.

• Product pipeline includes commercializing healthcare air purification technology for broader applications.

• Management expects improved profitability through cost reductions and more efficient sales processes.